Twins got a lot of value in two pitchers received for Nelson Cruz

Once the emotion of trading away a very popular and productive player wears off, we're left with the fact that the Twins got a lot in return for a player on an expiring contract.

July 23, 2021 at 2:32PM
Joe Ryan (left) and Drew Strotman were the two Class AAA pitchers the Twins received in Thursday’s Nelson Cruz trade. (The Minnesota Star Tribune)

Nelson Cruz provided the Twins with exceptional value in his 258 games with the team, serving as the catalyst for back-to-back AL Central championship teams and being everything the Twins could have asked for on and off the field.

And when it was time to trade Cruz, with Year 3 of his tenure with the Twins dissolving in a sea of losses, he continued to provide that same exceptional value.

Minnesota found a motivated buyer in Tampa Bay, a team that quite frankly gave up far more for Cruz than I might have imagined. The Rays trail the Red Sox by just one game in the AL East and have an 81.5% chance to make the postseason, per FanGraphs.

Their offense has been solid, ranking seventh in the majors with 474 runs scored. But their designated hitters have just a .702 OPS, No. 13 out of 15 American League teams. Enter Cruz, whose .907 OPS should bring another jolt to that lineup.

With a player like Cruz, who is surely productive but has a more limited market as a DH than, say, a relief pitcher, you don't wait for all the offers to come in. If you find one you like, you take it.

And there's a lot to like about the two pitchers the Twins got from the Rays, as I talked about on Friday's Daily Delivery podcast.

If you don't see the podcast player, tap here to listen.

Righthanders Joe Ryan and Drew Strotman will both be 25 by the end of this season, and both have had nice seasons at Class AAA in what has been, outside of 13 innings at Class AA for Ryan in 2019, their first work above Class A.

Strotman had Tommy John surgery in June of 2018, cutting short that season after just nine starts at Class A. He made nine more starts at the tail end of 2019 between rookie ball and Class A. Then the pandemic wiped out 2020. Now he's at Class AAA, where he has posted a 7-2 record, 3.39 ERA and 62 strikeouts in 58.1 innings.

As a pair, Ryan and Strotman were ranked as the Nos. 10 and 17 prospects in the Rays' organization by MLB before the trade; Ryan is now the No. 6 prospect in the Twins' system and Strotman is No. 13 — a testament to the depth and strength, at least relatively speaking, of the Rays' system, one that is known for producing pitching.

They are also a little on the old side, though — no other prospects in the Twins' top 25 aside from Brent Rooker are older than Ryan and Strotman. But considering both were college pitchers who had a year wiped out by the pandemic, and Strotman lost a year to injury, they are still viable prospects.

Getting a pitcher at the trade deadline who is close to helping at the Major League level is not easy; the prevailing thought going into this year's deadline was that the Twins might have to settle for younger, less-developed prospects at Class A.

Instead, in what might be the first of several moves, the Twins didn't just get one pitcher on the cusp of the big leagues. They got two. It doesn't guarantee either will pan out, but at least the Twins will know sooner rather than later what they have.

It wouldn't be surprising to see one or both at Target Field before the year is over as the Twins try to sort out who might help them wipe away the taste of 2021 in 2022 and beyond.

about the writer

about the writer

Michael Rand

Columnist / Reporter

Michael Rand is the Star Tribune's Digital Sports Senior Writer and host/creator of the Daily Delivery podcast. In 25 years covering Minnesota sports at the Star Tribune, he has seen just about everything (except, of course, a Vikings Super Bowl).

See More

More from Randball

card image

When he was hired after the disastrous 2016 season to reshape the Twins, Derek Falvey brought a reputation for identifying and developing pitching talent. It took a while, but the pipeline we were promised is now materializing.

card image
card image